Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Patches for Opioid Reduction in Geriatric Rib Fracture Patients
NCT05714631Phase 4Terminated
- Sponsor
- Medical College of Wisconsin
- Start
- Oct 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of LidoPain in rib fracture (3 arms), sponsored by Medical College of Wisconsin. Primary endpoint: Oral Morphine Equivalent up to 1 week. Started Oct 2023; status: terminated.
02
Drugs
LidoPain
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT05714631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05714631.